- Home
- TIL vs ESSA Comparison
TIL vs ESSA Comparison
Compare TIL & ESSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- ESSA
- Stock Information
- Founded
- TIL 2018
- ESSA 1916
- Country
- TIL United States
- ESSA United States
- Employees
- TIL N/A
- ESSA N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- ESSA Banks
- Sector
- TIL Health Care
- ESSA Finance
- Exchange
- TIL Nasdaq
- ESSA Nasdaq
- Market Cap
- TIL 230.1M
- ESSA 184.4M
- IPO Year
- TIL 2021
- ESSA N/A
- Fundamental
- Price
- TIL $21.92
- ESSA $20.11
- Analyst Decision
- TIL Buy
- ESSA
- Analyst Count
- TIL 5
- ESSA 0
- Target Price
- TIL $119.00
- ESSA N/A
- AVG Volume (30 Days)
- TIL 387.8K
- ESSA 24.9K
- Earning Date
- TIL 08-12-2025
- ESSA 07-23-2025
- Dividend Yield
- TIL N/A
- ESSA 3.09%
- EPS Growth
- TIL N/A
- ESSA N/A
- EPS
- TIL N/A
- ESSA 1.55
- Revenue
- TIL N/A
- ESSA $66,345,000.00
- Revenue This Year
- TIL N/A
- ESSA $9.38
- Revenue Next Year
- TIL N/A
- ESSA N/A
- P/E Ratio
- TIL N/A
- ESSA $12.43
- Revenue Growth
- TIL N/A
- ESSA N/A
- 52 Week Low
- TIL $9.62
- ESSA $15.82
- 52 Week High
- TIL $92.00
- ESSA $22.22
- Technical
- Relative Strength Index (RSI)
- TIL 40.10
- ESSA 58.74
- Support Level
- TIL $25.80
- ESSA $18.62
- Resistance Level
- TIL $23.30
- ESSA $19.67
- Average True Range (ATR)
- TIL 3.63
- ESSA 0.35
- MACD
- TIL -1.84
- ESSA 0.10
- Stochastic Oscillator
- TIL 1.91
- ESSA 77.84
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About ESSA ESSA Bancorp Inc.
ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.